Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Metastatic Melanoma
NCT01840007Phase 2Completed
- Sponsor
- Centre Hospitalier Universitaire de Nice
- Start
- Aug 2011
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of metformin in melanoma, sponsored by Centre Hospitalier Universitaire de Nice. Primary endpoint: Response Rate at 6 months. Started Aug 2011; status: completed.
02
Drugs
metformin
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01840007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01840007.